Figure 2.
Summary of the effects of non-selective CB1R and CB2R agonists in in vitro and in vivo models and in patients with Alzheimer’s disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.